Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

SAN DIEGO--(BUSINESS WIRE)--The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks....

AMSTERDAM--(BUSINESS WIRE)--Nebius Group N.V. (NASDAQ: NBIS), the AI cloud company, today announced a new long-term AI infrastructure supply agreement with Meta, strengthening the collaboration between the companies. Under the five-year agreement, Nebius will provide $12 billion of dedicated capacity across multiple locations, based on one of the first large-scale deployments of the NVIDIA Vera Rubin platform. Nebius will deliver this capacity starting early 2027. Furthermore, in connection wit...

PARIS--(BUSINESS WIRE)--Corporate and investment banks face competition from non‑banks as client expectations rise and technology initiatives fail to live up to expectations....

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announces that a deadline is coming up on April 03, 2026, in the lawsuit pending for certain investors in Richtech Robotics Inc. (NASDAQ: RR) shares. Investors who purchased shares of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026 and 12:00 p.m. EST on January 29, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: April 03, 2026. NASDAQ: RR investors should conta...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' PanTracer™ LBx test has received coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostics Services Program....

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that it has entered into a securities purchase agreement with institutional and accredited investors to sell securities in a private placement financing (the “PIPE”) for gross proceeds of approximately $120 million, before deducting offering expenses. The financing...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 13.03.2026 GRDU.LN IE000J80JTL1 26,550,002.00 USD 1,510,527,386.08 56.894  ...

WASHINGTON--(BUSINESS WIRE)--FiscalNote Expands PolicyNote API to Deliver Complete, Primary-Source Trump Presidential Transcripts to AI Agents and Enterprise Systems...

--(BUSINESS WIRE)--UnitedHealthcare today announced the national expansion of its doula offering, now available to people enrolled in eligible health plans through their employer. Doula Support is designed to help improve maternal and infant health outcomes by giving more people access to non-clinical emotional, physical and educational support throughout their pregnancy, birth and the postpartum period. The United States continues to face the highest maternal mortality rate among high-income c...